January 30, 2019
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Read More
January 30, 2019
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Read More
January 30, 2019
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Read More
January 30, 2019
Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia
Read More
January 30, 2019
Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia
Read More
January 30, 2019
Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)
Read More
January 30, 2019
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Read More
January 30, 2019
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment
Read More
January 30, 2019
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
Read More
January 30, 2019
Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Read More
January 30, 2019
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Read More
January 30, 2019
Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis
Read More
Load More
X